ACM

ADAR1 Capital Management Portfolio holdings

AUM $616M
1-Year Est. Return 26.77%
This Quarter Est. Return
1 Year Est. Return
+26.77%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$520M
AUM Growth
+$34.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
253
New
Increased
Reduced
Closed

Top Buys

1
+$14.9M
2
+$9.17M
3
+$8.55M
4
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$6.34M
5
RAPT icon
RAPT Therapeutics
RAPT
+$5.85M

Top Sells

1
+$11.7M
2
+$10.9M
3
+$9.18M
4
EDR
Endeavor Group Holdings, Inc.
EDR
+$6.59M
5
SNY icon
Sanofi
SNY
+$4.8M

Sector Composition

1 Healthcare 80.96%
2 Financials 3.39%
3 Industrials 0.19%
4 Consumer Discretionary 0.06%
5 Utilities 0.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PTGX icon
1
Protagonist Therapeutics
PTGX
$4.82B
$45.4M 8.44%
939,669
-80,664
BOXX icon
2
Alpha Architect 1-3 Month Box ETF
BOXX
$8.11B
$37.6M 6.98%
337,125
+11,675
ROIV icon
3
Roivant Sciences
ROIV
$11.8B
$35.1M 6.52%
3,483,404
-25,290
ZLAB icon
4
Zai Lab
ZLAB
$3.15B
$34M 6.31%
940,858
-104,979
IMVT icon
5
Immunovant
IMVT
$3.05B
$16.6M 3.07%
968,866
+181,388
CYTK icon
6
Cytokinetics
CYTK
$6.99B
$15.7M 2.92%
390,729
-23,480
KROS icon
7
Keros Therapeutics
KROS
$421M
$15.1M 2.81%
1,486,461
+1,463,215
ABVX
8
Abivax
ABVX
$7.22B
$13.8M 2.56%
2,210,019
+696,626
BIL icon
9
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$42B
$12.4M 2.31%
135,585
+3,799
BBIO icon
10
BridgeBio Pharma
BBIO
$10.5B
$11.7M 2.18%
339,635
-339,222
IKT icon
11
Inhibikase Therapeutics
IKT
$117M
$11.2M 2.08%
5,122,105
+19,100
SWTX
12
DELISTED
SpringWorks Therapeutics
SWTX
$9.17M 1.7%
+207,778
SHY icon
13
iShares 1-3 Year Treasury Bond ETF
SHY
$24.2B
$8.55M 1.59%
+103,337
TEVA icon
14
Teva Pharmaceuticals
TEVA
$22.2B
$8.05M 1.49%
523,767
+377,096
SRPT icon
15
Sarepta Therapeutics
SRPT
$2.36B
$7.84M 1.46%
122,921
+82,919
PCSC
16
Perceptive Capital Solutions
PCSC
$118M
$7.72M 1.43%
750,000
CGON icon
17
CG Oncology
CGON
$3.16B
$7.37M 1.37%
301,134
+85,384
RAPT icon
18
RAPT Therapeutics
RAPT
$485M
$7.28M 1.35%
746,346
+599,557
ABUS icon
19
Arbutus Biopharma
ABUS
$845M
$6.56M 1.22%
1,879,114
+324,312
ITCI
20
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$6.34M 1.18%
+48,044
RVMD icon
21
Revolution Medicines
RVMD
$10.1B
$6.26M 1.16%
177,136
+7,136
AVR
22
Anteris Technologies
AVR
$176M
$6.11M 1.13%
1,678,063
+625,095
AAM
23
AA Mission Acquisition Corp
AAM
$463M
$6.03M 1.12%
578,359
+18,160
SAGE
24
DELISTED
Sage Therapeutics
SAGE
$5.9M 1.1%
742,495
+723,295
ETNB icon
25
89bio
ETNB
$2.19B
$5.85M 1.09%
804,220
+289,082
1
2 3 4 5